• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $MACA

    Moringa Acquisition Corp

    Subscribe to $MACA
    $MACA
    Blank Checks
    Finance

    Moringa Acquisition Corp does not have significant operations. The company intends to acquire assets and businesses through a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. It focuses on pursuing opportunities in technology-based businesses or industries in Israel. The company was incorporated in 2020 and is based in New York, New York.

    IPO Year: 2021

    Exchange: NASDAQ

    Website: moringaac.com

    Recent Analyst Ratings for Moringa Acquisition Corp

    DatePrice TargetRatingAnalyst
    See more ratings

    Moringa Acquisition Corp SEC Filings

    See more
    • Amendment: SEC Form SCHEDULE 13G/A filed by Moringa Acquisition Corp

      SCHEDULE 13G/A - Moringa Acquisition Corp (0001835416) (Subject)

      8/27/24 11:00:41 AM ET
      $MACA
      Blank Checks
      Finance
    • SEC Form 15-12G filed by Moringa Acquisition Corp

      15-12G - Moringa Acquisition Corp (0001835416) (Filer)

      8/26/24 9:49:09 AM ET
      $MACA
      Blank Checks
      Finance
    • Moringa Acquisition Corp filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits

      8-K - Moringa Acquisition Corp (0001835416) (Filer)

      8/21/24 4:05:08 PM ET
      $MACA
      Blank Checks
      Finance
    • SEC Form 25-NSE filed by Moringa Acquisition Corp

      25-NSE - Moringa Acquisition Corp (0001835416) (Subject)

      8/15/24 4:51:46 PM ET
      $MACA
      Blank Checks
      Finance
    • SEC Form 10-Q filed by Moringa Acquisition Corp

      10-Q - Moringa Acquisition Corp (0001835416) (Filer)

      8/13/24 10:30:44 AM ET
      $MACA
      Blank Checks
      Finance
    • Moringa Acquisition Corp filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - Moringa Acquisition Corp (0001835416) (Filer)

      8/12/24 4:05:34 PM ET
      $MACA
      Blank Checks
      Finance
    • SEC Form DEFM14A filed by Moringa Acquisition Corp

      DEFM14A - Moringa Acquisition Corp (0001835416) (Filer)

      7/17/24 9:13:54 AM ET
      $MACA
      Blank Checks
      Finance
    • Moringa Acquisition Corp filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

      8-K - Moringa Acquisition Corp (0001835416) (Filer)

      6/24/24 4:43:23 PM ET
      $MACA
      Blank Checks
      Finance
    • SEC Form 10-Q filed by Moringa Acquisition Corp

      10-Q - Moringa Acquisition Corp (0001835416) (Filer)

      5/15/24 4:05:41 PM ET
      $MACA
      Blank Checks
      Finance
    • Moringa Acquisition Corp filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

      8-K - Moringa Acquisition Corp (0001835416) (Filer)

      4/3/24 11:22:27 AM ET
      $MACA
      Blank Checks
      Finance

    Moringa Acquisition Corp Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Hudson Bay Capital Management Lp disposed of $4,253,473 worth of Class A Ordinary Shares (401,271 units at $10.60)

      4 - Moringa Acquisition Corp (0001835416) (Issuer)

      8/24/23 2:31:41 PM ET
      $MACA
      Blank Checks
      Finance
    • SEC Form 3: New insider Hudson Bay Capital Management Lp claimed ownership of 401,271 units of Class A Ordinary Shares

      3 - Moringa Acquisition Corp (0001835416) (Issuer)

      4/5/23 4:59:51 PM ET
      $MACA
      Blank Checks
      Finance

    Moringa Acquisition Corp Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more

    Moringa Acquisition Corp Press Releases

    Fastest customizable press release news feed in the world

    See more
    • SEC Form SC 13G/A filed by Moringa Acquisition Corp (Amendment)

      SC 13G/A - Moringa Acquisition Corp (0001835416) (Subject)

      2/14/24 6:28:12 AM ET
      $MACA
      Blank Checks
      Finance
    • SEC Form SC 13G/A filed by Moringa Acquisition Corp (Amendment)

      SC 13G/A - Moringa Acquisition Corp (0001835416) (Subject)

      2/12/24 4:24:57 PM ET
      $MACA
      Blank Checks
      Finance
    • SEC Form SC 13G/A filed by Moringa Acquisition Corp (Amendment)

      SC 13G/A - Moringa Acquisition Corp (0001835416) (Subject)

      2/8/24 1:16:56 PM ET
      $MACA
      Blank Checks
      Finance
    • SEC Form SC 13G filed by Moringa Acquisition Corp

      SC 13G - Moringa Acquisition Corp (0001835416) (Subject)

      1/26/24 8:29:53 AM ET
      $MACA
      Blank Checks
      Finance
    • SEC Form SC 13G/A filed by Moringa Acquisition Corp (Amendment)

      SC 13G/A - Moringa Acquisition Corp (0001835416) (Subject)

      9/11/23 4:20:34 PM ET
      $MACA
      Blank Checks
      Finance
    • SEC Form SC 13G/A filed by Moringa Acquisition Corp (Amendment)

      SC 13G/A - Moringa Acquisition Corp (0001835416) (Subject)

      3/10/23 4:19:00 PM ET
      $MACA
      Blank Checks
      Finance
    • SEC Form SC 13G filed by Moringa Acquisition Corp

      SC 13G - Moringa Acquisition Corp (0001835416) (Subject)

      2/16/23 1:51:52 PM ET
      $MACA
      Blank Checks
      Finance
    • SEC Form SC 13G filed by Moringa Acquisition Corp

      SC 13G - Moringa Acquisition Corp (0001835416) (Subject)

      2/14/23 1:10:12 PM ET
      $MACA
      Blank Checks
      Finance
    • SEC Form SC 13G/A filed by Moringa Acquisition Corp (Amendment)

      SC 13G/A - Moringa Acquisition Corp (0001835416) (Subject)

      2/14/23 6:02:00 AM ET
      $MACA
      Blank Checks
      Finance
    • SEC Form SC 13G filed by Moringa Acquisition Corp

      SC 13G - Moringa Acquisition Corp (0001835416) (Subject)

      2/13/23 12:41:49 PM ET
      $MACA
      Blank Checks
      Finance
    • PESG Releases Report on Silexion Therapeutics: Pioneering RNAi Technology in the Fight Against KRAS-Driven Cancers

      Report covers Silexion Therapeutics (NASDAQ:SLXN), a disruptive player in the precision oncology space, developing innovative RNAi therapies targeting KRAS-driven cancers, highlighting the company's impressive clinical achievements and unique approach alongside industry drivers including the increasing M&A activity in the space Silexion Therapeutics (NASDAQ:SLXN) has emerged an intriguing yet under the radar player in the precision oncology space, focusing on developing innovative RNA interference (RNAi) therapies for KRAS-driven cancers. As a recently de-SPACed company following its merger with Moringa Acquisition Corp (NASDAQ:MACA), Silexion presents an interesting opportunity in the rap

      9/9/24 7:32:00 AM ET
      $MACA
      $SLXN
      Blank Checks
      Finance
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • Silexion Therapeutics Ltd. and Moringa Acquisition Corp Announce Closing of their Business Combination

      MODI'IN, Israel and NEW YORK, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Silexion Therapeutics Ltd. ("Silexion"), a clinical-stage, oncology-focused biotechnology company and Moringa Acquisition Corp (NASDAQ:MACA) ("Moringa"), a publicly-traded special purpose acquisition company, today announced the completion of their previously announced business combination (the "Business Combination") with Biomotion Sciences (the "combined company"), a recently formed entity. The combined company's name is changing from Biomotion Sciences to "Silexion Therapeutics Corp", and its ordinary shares and warrants are expected to begin trading on Nasdaq under the tickers "SLXN" and "SLXNW", respectively, on August 16

      8/15/24 4:05:00 PM ET
      $MACA
      Blank Checks
      Finance
    • Silexion, a Clinical-Stage, Oncology-Focused Biotechnology Company, to Become Publicly Traded Via Business Combination with Moringa Acquisition Corp

                                             Silexion's first generation product, Loder™, successfully tested in a multinational Phase 2a clinical trial in patients with non-resectable pancreatic cancer which harbors an oncogene believed to be a major driver of the cancer In combination with chemotherapy, Loder resulted in a median overall survival (OS) advantage of 9.3 months over chemotherapy alone (22.7 vs 13.4 months) Modi'in, Israel and New York, New York, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Moringa Acquisition Corp (NASDAQ:MACA) ("Moringa"), a special purpose acquisition company, today announced it has entered into a business combination agreement with Silexion Ltd. ("Silexion"), a cli

      2/22/24 8:27:00 AM ET
      $MACA
      Blank Checks
      Finance
    • MORINGA ACQUISITION CORP ANNOUNCES CONTRIBUTION TO TRUST ACCOUNT IN CONNECTION WITH PROPOSED EXTENSION

      New York, NY, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Moringa Acquisition Corp (NASDAQ:MACA) ("Moringa" or the "Company") announced today that, in connection with its previously announced extraordinary general meeting in lieu of the 2023 annual general meeting of shareholders of the Company to be held at 9:00 a.m. Eastern Time/4:00 p.m. local (Israel) time on August 16, 2023 (the "Extraordinary Meeting") for the purpose of considering and voting on, among other proposals, a proposal to extend the date by which the Company must consummate an initial business combination (the "Extension") from August 19, 2023 (the "Current Termination Date") to August 19, 2024 or such earlier date as may be determ

      8/15/23 9:25:00 AM ET
      $MACA
      Blank Checks
      Finance
    • MORINGA ACQUISITION CORP ANNOUNCES ADJOURNMENT OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS TO FEBRUARY 9, 2023

      New York, NY, Feb. 07, 2023 (GLOBE NEWSWIRE) --  Moringa Acquisition Corp (NASDAQ:MACA) ("Moringa" or the "Company") announced today that, the extraordinary general meeting in lieu of the 2022 annual general meeting of shareholders of the Company (the "Extraordinary Meeting"), originally scheduled to be held at 9:00 a.m. Eastern Time/4:00 p.m. local (Israel) time on February 7, 2023, was convened and then adjourned, without conducting any business, to recommence at 9:00 a.m. Eastern Time/4:00 p.m. local (Israel) time on February 9, 2023 as a virtual meeting via live webcast at https://www.cstproxy.com/moringaac/2023. The Extraordinary Meeting is being held for the purpose of considering a

      2/7/23 4:05:00 PM ET
      $MACA
      Blank Checks
      Finance
    • MORINGA ACQUISITION CORP ANNOUNCES CONTRIBUTION TO TRUST ACCOUNT IN CONNECTION WITH PROPOSED EXTENSION

      New York, NY, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Moringa Acquisition Corp (NASDAQ:MACA)  ("Moringa" or the "Company") announced today that, in connection with its previously announced extraordinary general meeting in lieu of the 2022 annual general meeting of shareholders of the Company to be held at 9:00 a.m. Eastern Time/4:00 p.m. local (Israel) time on February 7, 2023 (the "Extraordinary Meeting") for the purpose of considering and voting on, among other proposals, a proposal to extend the date by which the Company must consummate an initial business combination (the "Extension") from February 19, 2023 (the "Original Termination Date") to August 19, 2023 or such earlier date as may be

      1/26/23 4:05:00 PM ET
      $MACA
      Blank Checks
      Finance
    • Holisto, a Technology-Based Online Travel Booking Platform, to Become Publicly Traded Via Business Combination with Moringa Acquisition Corp

      Holisto's advanced AI technology addresses the fragmented and complex travel booking market, providing consumers with a more affordable and personalized offeringSince commercial product launch in Q2 2020, Holisto's online booking platform has gained significant market acceptanceTransaction enables Holisto to scale its customer acquisition and brand awareness strategy Rishon Le'Zion, Israel and New York, New York, June 13, 2022 (GLOBE NEWSWIRE) -- Holisto Ltd, a technology based online travel booking platform ("Holisto" or the "Company"), and Moringa Acquisition Corp (NASDAQ:MACA, "Moringa"))), a special purpose acquisition company, today announced they have entered into a busines

      6/13/22 5:09:00 PM ET
      $MACA
      Blank Checks
      Finance
    • Moringa Acquisition Corp Files its Annual Report for the 2021 Year

      NEW YORK, NY, April 05, 2022 (GLOBE NEWSWIRE) -- Moringa Acquisition Corp (NasdaqCM: MACA, MACAU and MACAW) (the "Company") announced that it filed its annual report on Form 10-K for the year ended December 31, 2021 with the Securities and Exchange Commission on March 31, 2022. Copies of the annual report and other filings are available online through the Company's website, https://www.moringaac.com/, or by accessing the Securities and Exchange Commission's website, www.sec.gov. Copies may also be obtained from the Company, Attn: Gil Maman, 250 Park Avenue, 7th Floor, New York, NY 11040, or by email: [email protected]. About Moringa Acquisition Corp Moringa Acquisition Corp was f

      4/5/22 7:33:44 AM ET
      $MACA
      Blank Checks
      Finance
    • Alpha Tau Medical Ltd. Appoints Ruth Alon to its Board of Directors

      JERUSALEM, March 21, 2022 /PRNewswire/ -- Alpha Tau Medical Ltd. (NASDAQ:DRTS), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, today announced the appointment of Ms. Ruth (Ruti) Alon to its Board of Directors, effective immediately. "We are pleased to welcome Ruti as the newest member of our Board of Directors," said Uzi Sofer, Chief Executive Officer and Chairman of Alpha Tau. "Ruti's extensive knowledge and experience advising healthcare companies through financial and strategic operations will be a tremendous asset to the Company. We are eager to have her on board and benefit from her insights into our corporate and clinical plan as we grow the Company." Ruti

      3/21/22 4:05:00 PM ET
      $DRTS
      $MACA
      $VBLT
      Medical/Dental Instruments
      Health Care
      Blank Checks
      Finance

    Moringa Acquisition Corp Leadership Updates

    Live Leadership Updates

    See more
    • Alpha Tau Medical Ltd. Appoints Ruth Alon to its Board of Directors

      JERUSALEM, March 21, 2022 /PRNewswire/ -- Alpha Tau Medical Ltd. (NASDAQ:DRTS), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, today announced the appointment of Ms. Ruth (Ruti) Alon to its Board of Directors, effective immediately. "We are pleased to welcome Ruti as the newest member of our Board of Directors," said Uzi Sofer, Chief Executive Officer and Chairman of Alpha Tau. "Ruti's extensive knowledge and experience advising healthcare companies through financial and strategic operations will be a tremendous asset to the Company. We are eager to have her on board and benefit from her insights into our corporate and clinical plan as we grow the Company." Ruti

      3/21/22 4:05:00 PM ET
      $DRTS
      $MACA
      $VBLT
      Medical/Dental Instruments
      Health Care
      Blank Checks
      Finance